ranitidine has been researched along with Mast Cell Activation Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daens, S; Grossin, D; Hermanns-Lê, T; Manicourt, D; Peeters, D | 1 |
| Carter, MC; Diaz, LZ; Jenkinson, HA; Levy, ML; Lundgren, AD | 1 |
| Dahlén, B; Dahlén, SE; Gülen, T; Hägglund, H; Nilsson, G; Sander, B | 1 |
| Langner, C; Siegel, C; Thonhofer, R; Trummer, M | 1 |
| Bruckner, NV | 1 |
| Akimoto, S; Amano, H; Hashimoto, T; Kanbe, N; Kurimoto, F; Kurosawa, M; Miyachi, Y; Takeuchi, Y; Yamashita, T | 1 |
| Dotan, I; Levo, Y; Sade, K | 1 |
| Crawhall, JC; Wilkinson, RD | 1 |
1 review(s) available for ranitidine and Mast Cell Activation Disease
| Article | Year |
|---|---|
Management of a neonate with diffuse cutaneous mastocytosis: Case report and literature review.
Topics: Cetirizine; Diphenhydramine; Drug Therapy, Combination; Gene Expression Regulation, Developmental; Humans; Infant, Newborn; Male; Mastocytosis; Prognosis; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit; Ranitidine; Severity of Illness Index; Treatment Outcome | 2019 |
7 other study(ies) available for ranitidine and Mast Cell Activation Disease
| Article | Year |
|---|---|
[Severe Mast Cell Activation Syndrome in a 15-year-old patient with an hypermobile Ehlers-Danlos syndrome].
Topics: Acetates; Adolescent; Antioxidants; Ascorbic Acid; Cetirizine; Cyclopropanes; Ehlers-Danlos Syndrome; Histamine H1 Antagonists, Non-Sedating; Histamine H2 Antagonists; Humans; Male; Mastocytosis; Quinolines; Ranitidine; Sulfides | 2018 |
Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis.
Topics: Acetates; Adult; Anaphylaxis; Cyclopropanes; Delayed Diagnosis; Drug Therapy, Combination; Epinephrine; Fatigue; Flushing; Histamine Antagonists; Humans; Leukotriene Antagonists; Loratadine; Male; Mastocytosis; Quinolines; Ranitidine; Recurrence; Sulfides | 2014 |
Mastocytic enterocolitis as a rare cause of chronic diarrhea in a patient with rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Biopsy; Chronic Disease; Diagnosis, Differential; Diarrhea; Drug Therapy, Combination; Enterocolitis; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Immunoglobulin E; Intestinal Mucosa; Loratadine; Male; Mast Cells; Mastocytosis; Methotrexate; Middle Aged; Ranitidine; Tryptases | 2011 |
Iatrogenic xanthoderma.
Topics: Female; Histamine H2 Antagonists; Humans; Iatrogenic Disease; Jaundice; Mastocytosis; Middle Aged; Pigmentation Disorders; Quinolines; Ranitidine | 2008 |
Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis.
Topics: Adult; Biopsy; Chymases; Dinoprostone; Histamine; Humans; Infant; Ketotifen; Leukotrienes; Male; Mast Cells; Mastocytosis; Ranitidine; Serine Endopeptidases; Thromboxane B2; Tryptases; Urticaria Pigmentosa | 1997 |
[Systemic mastocytosis].
Topics: Aged; Drug Therapy, Combination; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Hydroxyzine; Male; Mastocytosis; Ranitidine | 2000 |
Systemic mastocytosis: management of an unusual case with histamine (H1 and H2) antagonists and cyclooxygenase inhibition.
Topics: Cimetidine; Cyclooxygenase Inhibitors; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Male; Mastocytosis; Middle Aged; Ranitidine; Tachycardia; Urticaria Pigmentosa | 1987 |